跳至主要内容
临床试验/DRKS00010717
DRKS00010717已完成不适用

Identification of predictors associated with persisting PAIN in patients with rheumatoid Arthritis (RA) and CONTROLled disease activity - PAIN-CONTRO

AbbVie Deutschland GmbH Co. KG0 个研究点目标入组 647 人开始时间: 2016年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
647

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • - Adult patients with a confirmed diagnosis of rheumatoid arthritis according to American College of Rheumatology (ACR) 2010 criteria with active disease (DAS28 = 3.2) plus SJC > 3, CRP above the upper limit of normal or normal CRP value and planned initiation or escalation of anti-inflammatory Treatment
  • - Disease duration (RA) = 8 years
  • - Severe Pain (VAS (0-100) = 50))
  • - Patients with the intellectual capacity to take part in this study
  • - Adult patients whose signed written informed consent has been obtained

排除标准

  • - Patients with a history of chronically manifested pain due to degenerative joint disease, previous surgery, myofascial or ligament dysfunction preceding the flare (active disease inclusion criterion)
  • - Patients with Fibromyalgia syndrome
  • - Patients with diabetic neuropathy
  • - Patients with Psoriasis

研究者

相似试验